Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 15;4(12):100559.
doi: 10.1016/j.xkme.2022.100559. eCollection 2022 Dec.

Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study

Affiliations

Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study

Vedika M Karandikar et al. Kidney Med. .

Abstract

Rationale & objective: Recent literature suggests improvement in kidney function after percutaneous valvular replacement therapies, implying a pathophysiological contribution of valvular heart disease to chronic kidney disease (CKD). However, this association has not been investigated epidemiologically. We aimed to assess the association of valvular abnormality with prevalent and incident CKD.

Study design: Cross-sectional and prospective analyses.

Setting & participants: Community-dwelling participants (mean age 75.5 [standard deviation 5.1] years) from the Atherosclerosis Risk in Communities study (2011-2013).

Exposure: Valvular abnormality defined as echocardiography-based aortic stenosis, aortic regurgitation, and mitral regurgitation.

Outcomes: Prevalent CKD was defined as estimated glomerular filtration rate (eGFR]) <60 mL/min/1.73 m2. Incident CKD was defined as progression to eGFR <60 mL/min/1.73 m2 with ≥25% decline or hospitalization/deaths with CKD diagnosis.

Analytical approach: We cross-sectionally evaluated the association between valvular abnormality and prevalent CKD with logistic regression in 5,216 participants. Then, 3,752 participants without prevalent CKD were analyzed for incident CKD using Cox models.

Results: There were 1.4% (n = 74) with any aortic stenosis, 10.6% (n = 555) with any aortic regurgitation, and 43.1% (n = 2,249) with any mitral regurgitation. After adjustment for potential confounders, any mitral regurgitation and moderate/severe aortic regurgitation showed significant associations with prevalent CKD (adjusted OR, 1.17 [95% CI, 1.03-1.34] and 2.82 [95% CI, 1.12-7.10]), as did any aortic stenosis in a sensitivity analysis with prevalent CKD defined including albuminuria ≥30 mg/g (1.83 [95% CI, 1.10-3.05]). Only any aortic stenosis showed an independent association with incident CKD (adjusted HR, 2.12 [95% CI, 1.13-4.00]).

Limitations: Despite a relatively large study population, some subgroups had small numbers. Although we minimized reverse causation, we cannot completely rule it out.

Conclusions: Different valvular abnormality types were associated with prevalent CKD. Only aortic stenosis was robustly associated with incident CKD. These findings suggest an etiological link between valvular abnormality and CKD, highlighting the importance of clinical attention to kidney function in individuals with aortic stenosis.

Keywords: Aortic regurgitation; aortic stenosis; chronic kidney disease; mitral regurgitation; valvular abnormality.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Flowchart of the study. Abbreviations: ACR, albumin-to-creatinine ratio; ARIC, Atherosclerosis Risk in Communities; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.
Figure 2
Figure 2
Cumulative incidence of CKD according to presence or absence of valvular abnormality. Abbreviation: CKD, chronic kidney disease.

References

    1. Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011. doi: 10.1016/S0140-6736(06)69208-8. - DOI - PubMed
    1. Iung B., Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162–172. doi: 10.1038/nrcardio.2010.202. - DOI - PubMed
    1. Reinöhl J., Kaier K., Reinecke H., et al. Effect of availability of transcatheter aortic-valve replacement on clinical practice. N Engl J Med. 2015;373(25):2438–2447. doi: 10.1056/NEJMoa1500893. - DOI - PubMed
    1. Deuschl F.G., Schofer N., Lubos E., et al. MitraClip-data analysis of contemporary literature. J Thorac Dis. 2015;7(9):1509–1517. doi: 10.3978/j.issn.2072-1439.2015.07.38. - DOI - PMC - PubMed
    1. Leon M.B., Smith C.R., Mack M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607. doi: 10.1056/NEJMoa1008232. - DOI - PubMed